Understanding how lung cells repair after COVID-19 infection
Coordinated regeneration of lung epithelial and endothelial compartments
This study is looking at how lung cells heal after a COVID-19 infection, especially for people with serious breathing problems, to find new ways to help them recover better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10907512 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the regeneration of lung cells, specifically focusing on both epithelial and endothelial cells after infection with the COVID-19 virus. The study aims to understand how these cells communicate and influence each other's repair processes, particularly in the context of acute respiratory distress syndrome (ARDS). By examining specific signaling pathways and factors that promote healing, the research seeks to uncover new therapeutic targets that could enhance recovery in patients suffering from severe respiratory illnesses.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced severe COVID-19 symptoms or ARDS and are in the recovery phase.
Not a fit: Patients with mild COVID-19 symptoms or those who have not been hospitalized for respiratory issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients recovering from COVID-19 and other respiratory infections, potentially reducing mortality and enhancing lung function.
How similar studies have performed: Previous research has shown promise in understanding lung regeneration mechanisms, but this specific approach focusing on endothelial and epithelial coordination is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Vaughan, Andrew — University of Pennsylvania
- Study coordinator: Vaughan, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.